Evoke Pharma CEO David Gonyer's 2021 pay jumps 39% to $1.6M
Evoke Pharma reports 2021 executive compensation
By ExecPay News
Published: March 15, 2022
Evoke Pharma reported fiscal year 2021 executive compensation information on March 15, 2022.
In 2021, three executives at Evoke Pharma received on average a compensation package of $1.3M, a 42% increase compared to previous year.
Average pay of disclosed executives at Evoke Pharma
David A. Gonyer, Chief Executive Officer, received $1.6M in total, which increased by 39% compared to 2020. 55% of Gonyer's compensation, or $889K, was in option awards. Gonyer also received $127K in bonus, $550K in salary, as well as $60K in other compensation.
Matthew J. D'Onofrio, Secretary, received a compensation package of $1.2M, which increased by 41% compared to previous year. 55% of the compensation package, or $642K, was in option awards.
Marilyn T. Carlson, Chief Medical Officer, earned $1.1M in 2021, a 49% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 15, 2022.